These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


91 related items for PubMed ID: 2549353

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
    Chau RM, Teo PM, Kam MK, Leung SF, Cheung KY, Chan AT.
    Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Carbon ion radiotherapy for chordomas and low-grade chondrosarcomas of the skull base. Results in 67 patients.
    Schulz-Ertner D, Nikoghosyan A, Thilmann C, Haberer T, Jäkel O, Karger C, Scholz M, Kraft G, Wannenmacher M, Debus J.
    Strahlenther Onkol; 2003 Sep; 179(9):598-605. PubMed ID: 14628125
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Increased efficacy of radiation therapy by use of proton beam.
    Suit HD, Goitein M, Munzenrider J, Verhey L, Urie M, Gragoudas E, Koehler A, Gottschalk B, Sisterson J, Tatsuzaki H.
    Strahlenther Onkol; 1990 Jan; 166(1):40-4. PubMed ID: 2154047
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H, Kooy H, Trofimov A, Farr J, Munzenrider J, DeLaney T, Loeffler J, Clasie B, Safai S, Paganetti H.
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [Abstract] [Full Text] [Related]

  • 52. Proton therapy for base of skull chordoma: a report for the Royal College of Radiologists. The Proton Therapy Working Party.
    Clin Oncol (R Coll Radiol); 2000 Feb; 12(2):75-9. PubMed ID: 10853743
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
    Chang JY, Zhang X, Wang X, Kang Y, Riley B, Bilton S, Mohan R, Komaki R, Cox JD.
    Int J Radiat Oncol Biol Phys; 2006 Jul 15; 65(4):1087-96. PubMed ID: 16682145
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Cauda equina tolerance to high-dose fractionated irradiation.
    Pieters RS, Niemierko A, Fullerton BC, Munzenrider JE.
    Int J Radiat Oncol Biol Phys; 2006 Jan 01; 64(1):251-7. PubMed ID: 15993548
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Temporal lobe reactions after carbon ion radiation therapy: comparison of relative biological effectiveness-weighted tolerance doses predicted by local effect models I and IV.
    Gillmann C, Jäkel O, Schlampp I, Karger CP.
    Int J Radiat Oncol Biol Phys; 2014 Apr 01; 88(5):1136-41. PubMed ID: 24661667
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.